Sorrento Announces a Potential Breakthrough in Superior Covid Detection
(Sorrento) Sorrento Therapeutics Inc. has announced an 81% sensitivity by COVISTIX for screening both symptomatic and asymptomatic Covid-19 infections. The 81% sensitivity is a superior rate compared to 62% reported…